Condensed Balance Sheet - USD ($)
|
Sep. 30, 2016 |
Dec. 31, 2015 |
| Current Assets: |
|
|
| Cash and cash equivalents |
$ 8,392,240
|
$ 10,199,440
|
| Marketable securities |
13,419,359
|
13,240,086
|
| Prepaid expenses and other current assets |
802,053
|
1,221,818
|
| Total Current Assets |
22,613,652
|
24,661,344
|
| Security Deposits |
30,785
|
30,785
|
| Equipment, Net |
97,040
|
112,900
|
| Total Assets |
22,741,477
|
24,805,029
|
| Current Liabilities: |
|
|
| Accounts payable and accrued expenses |
1,785,724
|
2,661,298
|
| Deferred Research and Development Arrangement |
468,750
|
525,000
|
| Other Liabilities |
85,900
|
104,020
|
| Warrant Liabilities |
3,161,591
|
2,739,163
|
| Total Liabilities |
5,501,965
|
6,029,481
|
| Commitments and Contingencies (note 14) |
|
|
| Stockholders' Equity: |
|
|
| Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding |
|
|
| Common stock, par value $0.0001, 500,000,000 authorized shares, 237,368,785 and 197,413,785 issued and outstanding |
23,737
|
19,741
|
| Additional paid-in capital |
131,719,157
|
124,490,712
|
| Accumulated other comprehensive loss |
(4,656)
|
(18,041)
|
| Accumulated deficit |
(114,498,726)
|
(105,716,864)
|
| Total Stockholders' Equity |
17,239,512
|
18,775,548
|
| Total Liabilities and Stockholders' Equity |
$ 22,741,477
|
$ 24,805,029
|